Untitled Document
www.expresshealthcare.in INSIGHT INTO THE BUSINESS OF HEALTHCARE
August 2008  
Untitled Document
Sections

Market
Strategy
Diabetes
Medicall
Healthcare Life
Weekend

Services
Subscribe/Renew
Archives/Search
Contact Us
Network Sites
Express Computer
CIO Decisions
Exp. Channel Business
Express Hospitality
Express TravelWorld
Express Pharma
Group Sites
ExpressIndia
Indian Express
Financial Express

Home - Market - Article

Upfront

Dr Lal PathLabs Bags 'Emerging India Award' 2008

Dr Lal PathLabs (LPL) has been awarded with 'CNBC TV18 Emerging India Award 2008' by ICICI Bank Business Banking in the pharmaceuticals and chemicals category. John Hutton, MP and Secretary of State for Business, Enterprise and Regulatory Reform, presented the award to Dr Arvind Lal, CMD and OP Manchanda, CEO, Dr Lal PathLabs in London. The guest of honour for the ceremony was LN Mittal, Chairman and CEO, Arcelor Steel. The ceremony was graced by Kamal Nath, Union Minister of Commerce and Industry and other distinguished guests from the corporate world. Speaking on the achievement, Dr Arvind Lal said, "This is a moment of joy for the entire LPL family. We have once again proved that team work is the bulwark of LPL." He further said, "This award is in recognition of our hard work and I dedicate this to our team, our shareholders and our valued customers, whose feedback and support have helped us become what we are today." While presenting the award, John Hutton said, "Winners of this award will be distinguished as new icons in the Indian industry. They will set an example for the other players in the industry and inspire them to put in better efforts. The new winners in the SME sector should emerge as a symbol of good corporate governance."

The pathology major has 29 laboratories across India, nine of which are in the National Capital Region (NCR). In recent times, the company has set up 26 Patient Service Centres in Delhi/NCR, besides centres in major towns like Mumbai, Kolkata, Patna, Ranchi, Amritsar, Ludhiana, Chandigarh, Jammu, Gorakhpur, Varanasi and Lucknow. The company has recently set up a state-of-the art 4,000 sq ft facility at its Gurgaon headquarters exclusively for clinical trial operations. Future plans include setting up a mega 82,000 sq. ft laboratory at Rohini in North Delhi, which is expected to be completed by year-end.

EH News Bureau

 


Untitled Document

Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.